Literature DB >> 19559099

Mustard gas exposure and carcinogenesis of lung.

Alireza Hosseini-khalili1, David D Haines, Ehsan Modirian, Mohammadreza Soroush, Shahriar Khateri, Rashmi Joshi, Kazem Zendehdel, Mostafa Ghanei, Charles Giardina.   

Abstract

UNLABELLED: Sulfur mustard (SM), also known as mustard gas, is an alkylating compound used as a chemical weapon in World War I and by Iraqi forces against Iranians and indigenous Iraqi Kurds during the Iran-Iraq War of the 1980s. Although SM is a proven carcinogen there are conflicting views regarding the carcinogenicity of a single exposure. The present study characterizes lung cancers formed in mustard gas victims from the Iran-Iraq War. METHODS AND MATERIALS: Demographic information and tumor specimens were collected from 20 Iranian male lung cancer patients with single high-dose SM exposures during the Iran-Iraq War. Formalin-fixed, paraffin-embedded lung cancers were analyzed by immunohistochemistry for p53 protein. In addition, DNA was extracted from the tissues, PCR amplified and sequenced to identify mutations in the p53 and KRAS genes associated with SM exposure.
RESULTS: A relatively early age of lung cancer onset (ranging from 28 to 73 with a mean of 48) in mustard gas victims, particularly those in the non-smoking population (mean age of 40.7), may be an indication of a unique etiology for these cancers. Seven of the 20 patients developed lung cancer before the age of 40. Five of 16 cancers from which DNA sequence data was obtainable provided information on eight p53 mutations (within exons 5-8). These mutations were predominately G to A transitions; a mutation consistent with the DNA lesion caused by SM. Two of the lung cancers had multiple p53 point mutations, similar to results obtained from factory workers chronically exposed to mustard agent. No mutations were detected in the KRAS gene. DISCUSSION: The distinguishing characteristics of lung carcinogenesis in these mustard gas victims suggest that a single exposure may increase the risk of lung cancer development in some individuals.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19559099      PMCID: PMC2811761          DOI: 10.1016/j.mrgentox.2009.05.022

Source DB:  PubMed          Journal:  Mutat Res        ISSN: 0027-5107            Impact factor:   2.433


  34 in total

Review 1.  p53: 25 years after its discovery.

Authors:  Lorne J Hofseth; S Perwez Hussain; Curtis C Harris
Journal:  Trends Pharmacol Sci       Date:  2004-04       Impact factor: 14.819

Review 2.  Incidence of lung, eye, and skin lesions as late complications in 34,000 Iranians with wartime exposure to mustard agent.

Authors:  Shahriar Khateri; Mostafa Ghanei; Saeed Keshavarz; Mohammad Soroush; David Haines
Journal:  J Occup Environ Med       Date:  2003-11       Impact factor: 2.162

3.  Potential false-positive results with antigen enhancement for immunohistochemistry of the p53 gene product in colorectal neoplasms.

Authors:  I O Baas; F M van den Berg; J W Mulder; M J Clement; R J Slebos; S R Hamilton; G J Offerhaus
Journal:  J Pathol       Date:  1996-03       Impact factor: 7.996

Review 4.  Granulocyte clearance by apoptosis in the resolution of inflammation.

Authors:  J Savill; C Haslett
Journal:  Semin Cell Biol       Date:  1995-12

5.  Report of the specialists appointed by the Secretary-General of the United Nations to investigate allegations by the Islamic Republic of Iran concerning the use of chemical weapons.

Authors:  F Abbas
Journal:  Arch Belg       Date:  1984

Review 6.  Molecular epidemiology of human cancer risk: gene-environment interactions and p53 mutation spectrum in human lung cancer.

Authors:  W P Bennett; S P Hussain; K H Vahakangas; M A Khan; P G Shields; C C Harris
Journal:  J Pathol       Date:  1999-01       Impact factor: 7.996

7.  Age trends of lung cancer stage at diagnosis. Implications for lung cancer screening in the elderly.

Authors:  M A O'Rourke; J R Feussner; P Feigl; J Laszlo
Journal:  JAMA       Date:  1987-08-21       Impact factor: 56.272

Review 8.  Dna adducts, mutations, and cancer 2000.

Authors:  K Hemminki; M Koskinen; H Rajaniemi; C Zhao
Journal:  Regul Toxicol Pharmacol       Date:  2000-12       Impact factor: 3.271

9.  The p53 gene is very frequently mutated in small-cell lung cancer with a distinct nucleotide substitution pattern.

Authors:  T Takahashi; T Takahashi; H Suzuki; T Hida; Y Sekido; Y Ariyoshi; R Ueda
Journal:  Oncogene       Date:  1991-10       Impact factor: 9.867

10.  p53 mutations in human lung tumors.

Authors:  C W Miller; K Simon; A Aslo; K Kok; J Yokota; C H Buys; M Terada; H P Koeffler
Journal:  Cancer Res       Date:  1992-04-01       Impact factor: 12.701

View more
  10 in total

1.  Bronchial leiomyoma in a chemical warfare victim-a causative agent or an incidental finding: A case report.

Authors:  Samad Behesthirouy; Farzad Kakaei; Ramin Azhough; Ashraf Fakhrjou
Journal:  Int J Surg Case Rep       Date:  2012-05-14

Review 2.  Sulfur mustard-induced pulmonary injury: therapeutic approaches to mitigating toxicity.

Authors:  Barry Weinberger; Jeffrey D Laskin; Vasanthi R Sunil; Patrick J Sinko; Diane E Heck; Debra L Laskin
Journal:  Pulm Pharmacol Ther       Date:  2010-09-17       Impact factor: 3.410

Review 3.  Possible Treatment Approaches of Sulfur Mustard-Induced Lung Disorders, Experimental and Clinical Evidence, an Updated Review.

Authors:  Mohammad Reza Khazdair; Mohammad Hossein Boskabady
Journal:  Front Med (Lausanne)       Date:  2022-04-29

4.  Treatment for sulfur mustard lung injuries; new therapeutic approaches from acute to chronic phase.

Authors:  Zohreh Poursaleh; Ali Amini Harandi; Ensieh Vahedi; Mostafa Ghanei
Journal:  Daru       Date:  2012-09-10       Impact factor: 3.117

5.  Capsaicinoids, chloropicrin and sulfur mustard: possibilities for exposure biomarkers.

Authors:  Maija Pesonen; Kirsi Vähäkangas; Mia Halme; Paula Vanninen; Heikki Seulanto; Matti Hemmilä; Markku Pasanen; Tapio Kuitunen
Journal:  Front Pharmacol       Date:  2010-12-20       Impact factor: 5.810

6.  The Quality of Life of Mustard Gas Victims: A Systematic Review.

Authors:  Mojtaba Satkin; Mostafa Ghanei; Abbas Ebadi; Sahar Allahverdi; Mahdi Elikaei
Journal:  Tanaffos       Date:  2017

Review 7.  Epidemiological Study of Lung Cancer in Iran: A Systematic Review.

Authors:  Hamid Salehiniya; Mohammadkarim Bahadori; Ghader Ghanizadeh; Mehdi Raei
Journal:  Iran J Public Health       Date:  2022-02       Impact factor: 1.479

Review 8.  Cancer Events After Acute or Chronic Exposure to Sulfur Mustard: A Review of the Literature.

Authors:  Seyed Mansour Razavi; Mohammad Abdollahi; Payman Salamati
Journal:  Int J Prev Med       Date:  2016-05-19

9.  Two Lung Cancer Development-Related Genes, Forkhead Box M1 (FOXM1) and Apolipoprotein E (APOE), are overexpressed in Bronchial of Patients after Long-Term Exposure to Sulfur Mustard.

Authors:  Eisa Tahmasbpour; Mostafa Ghanei; Yunes Panahi
Journal:  Iran J Pharm Res       Date:  2017       Impact factor: 1.696

Review 10.  Delayed Complications and Long-term Management of Sulfur Mustard Poisoning: Recent Advances by Iranian Researchers (Part I of II).

Authors:  Emadodin Darchini-Maragheh; Mahdi Balali-Mood
Journal:  Iran J Med Sci       Date:  2018-03
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.